Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma | Zendy

Arnaud Méjean | Zendy; Alain Ravaud | Zendy; Simon Thézenas | Zendy; Sandra Colas | Zendy; JeanBaptiste Beauval | Zendy; Karim Bensalah | Zendy; Lionnel Geoffrois | Zendy; Antoine Thiery-Vuillemin | Zendy; Laurent Cormier | Zendy; Hervé Lang | Zendy; Laurent Guy | Zendy; Gwénaëlle Gravis | Zendy; Frédéric Rolland | Zendy; Claude Linassier | Zendy; É. Lechevallier | Zendy; Christian Beisland | Zendy; Michael Aitchison | Zendy; Stéphane Oudard | Zendy; JeanJacques Patard | Zendy; C Théodore | Zendy; Christine Chevreau | Zendy; Brigitte Laguerre | Zendy; Jacques Hubert | Zendy; Marine GrossGoupil | Zendy; JeanChristophe Bernhard | Zendy; Laurence Albigès | Zendy; M.-O. Timsit | Zendy; Thierry Lebrét | Zendy; Bernard Escudier | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

Author(s) -

Arnaud Méjean,

Alain Ravaud,

Simon Thézenas,

Sandra Colas,

JeanBaptiste Beauval,

Karim Bensalah,

Lionnel Geoffrois,

Antoine Thiery-Vuillemin,

Laurent Cormier,

Hervé Lang,

Laurent Guy,

Gwénaëlle Gravis,

Frédéric Rolland,

Claude Linassier,

É. Lechevallier,

Christian Beisland,

Michael Aitchison,

Stéphane Oudard,

JeanJacques Patard,

C Théodore,

Christine Chevreau,

Brigitte Laguerre,

Jacques Hubert,

Marine GrossGoupil,

JeanChristophe Bernhard,

Laurence Albigès,

M.-O. Timsit,

Thierry Lebrét,

Bernard Escudier

Publication year - 2018

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1803675

Subject(s) - sunitinib , renal cell carcinoma , nephrectomy , medicine , urology , oncology , kidney

Cytoreductive nephrectomy has been the standard of care in metastatic renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies. However, the efficacy of targeted therapies has challenged this standard. We assessed the role of nephrectomy in patients with metastatic renal-cell carcinoma who were receiving targeted therapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research